↓ Skip to main content

Ficellomycin: an aziridine alkaloid antibiotic with potential therapeutic capacity

Overview of attention for article published in Applied Microbiology and Biotechnology, March 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
37 Mendeley
Title
Ficellomycin: an aziridine alkaloid antibiotic with potential therapeutic capacity
Published in
Applied Microbiology and Biotechnology, March 2018
DOI 10.1007/s00253-018-8934-4
Pubmed ID
Authors

Xihong He, Meng Li, Shuting Song, Xiaonong Wu, Jing Zhang, Guoguo Wu, Rong Yue, Huanhuan Cui, Siqing Song, Congcong Ma, Fuping Lu, Huitu Zhang

Abstract

Ficellomycin is an aziridine antibiotic produced by Streptomyces ficellus, which displays high in vitro activity against Gram-positive bacteria including multidrug resistant strains of Staphylococcus aureus. Compared to currently available antibiotics, ficellomycin exhibits a unique mechanism of action-it impairs the semiconservative DNA replication by inducing the formation of deficient 34S DNA fragments, which lack the ability to integrate into larger DNA pieces and eventually the complete bacterial chromosome. Until recently, some important progress has been made in research on ficellomycin synthesis and biosynthesis, opening the perspective to develop a new generation of antibiotics with better clinical performance than the currently used ones. In this review, we will cover the discovery and biological activity of ficellomycin, its biosynthesis, mode of action, and related synthetic analogs. The role of ficellomycin and its analogs as an important source of drug prototypes will be discussed together with future research prospects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Student > Ph. D. Student 4 11%
Student > Bachelor 3 8%
Student > Postgraduate 2 5%
Student > Doctoral Student 1 3%
Other 2 5%
Unknown 18 49%
Readers by discipline Count As %
Chemistry 5 14%
Biochemistry, Genetics and Molecular Biology 3 8%
Medicine and Dentistry 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Agricultural and Biological Sciences 2 5%
Other 3 8%
Unknown 19 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2018.
All research outputs
#18,922,529
of 24,119,703 outputs
Outputs from Applied Microbiology and Biotechnology
#6,246
of 8,034 outputs
Outputs of similar age
#244,229
of 333,181 outputs
Outputs of similar age from Applied Microbiology and Biotechnology
#96
of 146 outputs
Altmetric has tracked 24,119,703 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,034 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,181 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 146 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.